Guangyu Wang
Harbin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Treatment patterns and outcomes in advanced or metastatic gastric/gastroesophageal junction adenocarcinoma in China.
Journal: Future oncology (London, England)
Published: March 17, 2025
Comparative efficacy of cetuximab combined with FOLFOX or CAPEOX in first-line treatment of RAS/BRAF wild-type metastatic colorectal cancer: a multicenter case-control study.
Journal: Anti-cancer drugs
Published: February 04, 2025
Efficacy observation of sequential TAS-102 following regorafenib as a later-line treatment in patients with metastatic colorectal cancer: a cohort study.
Journal: Journal of gastrointestinal oncology
Published: January 15, 2025
A comparison between single and fractionated doses of albumin-bound paclitaxel in the treatment of advanced esophageal cancer: A multicenter case-control study.
Journal: Science progress
Published: November 19, 2024
Deep learning-driven survival prediction in pan-cancer studies by integrating multimodal histology-genomic data.
Journal: Briefings in bioinformatics
Published: October 10, 2024
A multicenter retrospective study of the combination of immune checkpoint inhibitors and chemotherapy regimens with or without liver metastasis for the first-line treatment of advanced gastric cancer.
Journal: Therapeutic advances in medical oncology
Published: July 14, 2024
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial.
Journal: Nature communications
Published: March 29, 2024
Envafolimab Inhibits the Growth of Gastric Cancer Cells with Low PD-L1 Expression through the DDX20/NF-κB/TNF-α Signaling Pathway.
Journal: Current cancer drug targets
Published: March 27, 2024
Nab-paclitaxel plus S-1 followed by gemcitabine-oxaliplatin as first-line alternating sequential treatment of pancreatic ductal adenocarcinoma.
Journal: The oncologist
Published: January 18, 2024
Combination of Anti-PD-1 and Electroacupuncture Induces a Potent Antitumor Immune Response in Microsatellite-Stable Colorectal Cancer.
Journal: Cancer immunology research
Published: April 11, 2023
A Retrospective Analysis of the Lauren Classification in the Choice of XELOX or SOX as an Adjuvant Chemotherapy for Gastric Cancer.
Journal: Current gene therapy
Published: March 09, 2023
Last Updated: 09/26/2026